(A)As used in this section, "health care professional" means any of the following who provide medical, dental, or other health-related diagnosis, care, or treatment:
(1)Individuals authorized under Chapter 4731. of the Revised Code to practice medicine and surgery, osteopathic medicine and surgery, or podiatric medicine and surgery;
(2)Registered nurses licensed under Chapter 4723. of the Revised Code, including advanced practice registered nurses, and licensed practical nurses licensed under that chapter ;
(3)Physician assistants licensed under Chapter 4730. of the Revised Code;
(4)Dentists and dental hygienists licensed under Chapter 4715. of the Revised Code;
(5)Optometrists licensed under Chapter 4725. of the Revised Code;
(6)Pharmacists licensed under Chapter 4729. of the
Free access — add to your briefcase to read the full text and ask questions with AI
(A) As used in this section, "health care professional" means any of the following who provide medical, dental, or other health-related diagnosis, care, or treatment:
(1) Individuals authorized under Chapter 4731. of the Revised Code to practice medicine and surgery, osteopathic medicine and surgery, or podiatric medicine and surgery;
(2) Registered nurses licensed under Chapter 4723. of the Revised Code, including advanced practice registered nurses, and licensed practical nurses licensed under that chapter ;
(3) Physician assistants licensed under Chapter 4730. of the Revised Code;
(4) Dentists and dental hygienists licensed under Chapter 4715. of the Revised Code;
(5) Optometrists licensed under Chapter 4725. of the Revised Code;
(6) Pharmacists licensed under Chapter 4729. of the Revised Code;
(7) Certified mental health assistants licensed under Chapter 4772. of the Revised Code.
(B) For matters related to activities conducted under the drug repository program, all of the following apply:
(1) A pharmacy, drug manufacturer, health care facility, or other person or government entity that donates or gives drugs to the program, and any person or government entity that facilitates the donation or gift, shall not be subject to liability in tort or other civil action for injury, death, or loss to person or property.
(2) A pharmacy, hospital, or nonprofit clinic that accepts or distributes drugs under the program shall not be subject to liability in tort or other civil action for injury, death, or loss to person or property, unless an action or omission of the pharmacy, hospital, or nonprofit clinic constitutes willful and wanton misconduct.
(3) A health care professional who accepts, dispenses, or personally furnishes drugs under the program on behalf of a pharmacy, hospital, or nonprofit clinic participating in the program, and the pharmacy, hospital, or nonprofit clinic that employs or otherwise uses the services of the health care professional, shall not be subject to liability in tort or other civil action for injury, death, or loss to person or property, unless an action or omission of the health care professional, pharmacy, hospital, or nonprofit clinic constitutes willful and wanton misconduct.
(4) The state board of pharmacy shall not be subject to liability in tort or other civil action for injury, death, or loss to person or property, unless an action or omission of the board constitutes willful and wanton misconduct.
(5) In addition to the civil immunity granted under division (B)(1) of this section, a pharmacy, drug manufacturer, health care facility, or other person or government entity that donates or gives drugs to the program, and any person or government entity that facilitates the donation or gift, shall not be subject to criminal prosecution for matters related to activities that it conducts or another party conducts under the program, unless an action or omission of the party that donates, gives, or facilitates the donation or gift of the drugs does not comply with the provisions of this chapter or the rules adopted under it.
(6) In the case of a drug manufacturer, the immunities from civil liability and criminal prosecution granted to another party under divisions (B)(1) and (5) of this section extend to the manufacturer when any drug it manufactures is the subject of an activity conducted under the program. This extension of immunities includes, but is not limited to, immunity from liability or prosecution for failure to transfer or communicate product or consumer information or the expiration date of a drug that is donated or given.
The Legislative Service Commission presents the text of this section as a composite of the section as amended by multiple acts of the General Assembly. This presentation recognizes the principle stated inR.C. 1.52(B)that amendments are to be harmonized if reasonably capable of simultaneous operation.
Last updated January 23, 2025 at 2:02 PM